BE880042A - 5-(2-imidazolin-2-yl)-aminopyrimidines substituees et leur procede de preparation. - Google Patents

5-(2-imidazolin-2-yl)-aminopyrimidines substituees et leur procede de preparation.

Info

Publication number
BE880042A
BE880042A BE0/198116A BE198116A BE880042A BE 880042 A BE880042 A BE 880042A BE 0/198116 A BE0/198116 A BE 0/198116A BE 198116 A BE198116 A BE 198116A BE 880042 A BE880042 A BE 880042A
Authority
BE
Belgium
Prior art keywords
aminopyrimidines
imidazolin
substituted
preparation process
preparation
Prior art date
Application number
BE0/198116A
Other languages
English (en)
French (fr)
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Publication of BE880042A publication Critical patent/BE880042A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE0/198116A 1978-11-15 1979-11-14 5-(2-imidazolin-2-yl)-aminopyrimidines substituees et leur procede de preparation. BE880042A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2849537A DE2849537C2 (de) 1978-11-15 1978-11-15 Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
BE880042A true BE880042A (fr) 1980-05-14

Family

ID=6054732

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/198116A BE880042A (fr) 1978-11-15 1979-11-14 5-(2-imidazolin-2-yl)-aminopyrimidines substituees et leur procede de preparation.

Country Status (4)

Country Link
JP (1) JPS5592383A (hu)
BE (1) BE880042A (hu)
DE (1) DE2849537C2 (hu)
ZA (1) ZA796148B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3016767A1 (de) * 1980-04-30 1981-11-05 Beiersdorf Ag, 2000 Hamburg Pyrimidylthioharnstoffe, diese enthaltende arzneimittel und deren verwendung
DE3423328A1 (de) * 1984-06-23 1986-01-02 Beiersdorf Ag, 2000 Hamburg Selbstklebendes pflaster
DE3423293C2 (de) * 1984-06-23 1995-08-24 Lohmann Therapie Syst Lts Selbstklebendes Pflaster
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel
DE19911371A1 (de) 1999-03-15 2000-09-21 Solvay Pharm Gmbh Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
CA2487541A1 (en) 2002-06-19 2003-12-31 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
KR20080090546A (ko) * 2006-01-27 2008-10-08 에프. 호프만-라 로슈 아게 Cns 장애 치료용 2-이미다졸의 용도
ES2369113T3 (es) * 2006-06-26 2011-11-25 Chemagis Ltd. Procedimiento mejorado para producir moxonidina.
RU2473545C2 (ru) 2007-02-02 2013-01-27 Ф.Хоффманн-Ля Рош Аг Новые 2-аминооксазолины в качестве лигандов taar1 для заболеваний цнс
MX2009008465A (es) 2007-02-15 2009-08-20 Hoffmann La Roche Nuevas 2-aminooxazolinas como ligandos de taar1.
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
DE102012215896A1 (de) 2012-09-07 2014-03-13 Wörwag Pharma GmbH & Co.KG Moxonidinsynthese mit Hilfe organischer Basen
ES2608004T3 (es) 2012-12-03 2017-04-05 WÖRWAG PHARMA GmbH & Co. KG Método mediante catálisis por transferencia de fase
EP2765131B1 (en) 2013-02-08 2016-11-23 Arevipharma GmbH Process for the production of Moxonidine
CR20180443A (es) 2016-03-17 2018-11-21 Hoffmann La Roche Derivado de morfolina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754832A (fr) * 1969-08-14 1971-02-15 Beecham Group Ltd Iminazolines
BE503170A (hu) * 1975-09-02

Also Published As

Publication number Publication date
JPS5592383A (en) 1980-07-12
JPS6354714B2 (hu) 1988-10-28
DE2849537C2 (de) 1983-03-17
ZA796148B (en) 1980-11-26
DE2849537A1 (de) 1980-05-22

Similar Documents

Publication Publication Date Title
IT7927284A0 (it) 5- (2-imidazolin-2-il)-aminopirimidine sostituite e processo per la loro preparazione.
FR2449699B1 (fr) Polyetherpolyamides et leur procede de preparation
BE880042A (fr) 5-(2-imidazolin-2-yl)-aminopyrimidines substituees et leur procede de preparation.
BE873447A (fr) Derives de 1,2,4-oxadiazole, leur procede de preparation et leur utilisation
BE876039A (fr) Nouvelles 4-quinolinylaminobenzoylpiperazines, leur procede de preparation
FR2458547B2 (fr) Nouvelles n-aryle azolones, leur procede de preparation et leur application en therapeutique
BE874181A (fr) Colorants reactifs, leur procede de preparation et leur application
BE858024A (fr) Nouvelles benzylurees substituees, leur procede de preparation et leur application comme insecticides
BE889049A (fr) Nouvelles quinoxaline-2-yl-ethenylcetones et leur procede de preparation
BE885946A (fr) Nouvelles pyridothienotriazines et leur procede de preparation
BE856220A (fr) Polyether-polyureides et procede de leur preparation
BE865805A (fr) 1,2,3-thiadiazol-3-in-5-ylidene-urees, leur procede de preparation et leur utilisation
BE845497A (fr) 3-phenylspiro-(isobenzofuranne-1,4'-pipieridine)-sulfenamides, leur procede de preparation et leurs applications
BE877051A (fr) Colorants reactifs, leur procede de preparation et leur application
BE855236A (fr) Derives omega-nor-aromatiques de 13,14-dehydro-prostaglandines et procede pour leur preparation
BE878127A (fr) Amides 1,2,3-triazolecarboxyliques, leur procede de preparation et leur utilisation
BE884652R (fr) Phenoxyalcoyl trialcoxysilanes et leur procede de preparation
FR2342291A1 (fr) Pyrrolobenzoxaza-alcanes, leur procede de preparation et leurs applications
BE851681A (fr) 2,9-dioxatricyclo-4,3,03,7- decanes et procede pour leur preparation
FR2424281B1 (fr) Phenoxyalcoyl trialcoxysilanes et leur procede de preparation
MA18466A1 (fr) Fongicides et procede pour leur preparation
BE868027A (fr) Nouvelles pyridazinylhydrazones et leur procede de preparation
BE857981R (fr) 2,9-dioxatricyclo (4,3,1,0 3,7) decanes et procede pour leur preparation
FR2341572A1 (fr) P-aminophenyl-as-triazine-diones substituees, leur procede de preparation et leurs applications
FR2342280A1 (fr) Phenylguanidines substituees, leur procede de preparation et leurs applications

Legal Events

Date Code Title Description
CCPA Application for a supplementary protection certificate

Free format text: 095C0011

CCPV Grant of a supplementary protection certificate

Free format text: 095C0011, EXPIRES:20041114

RE20 Patent expired

Owner name: BEIERSDORF - LILLY G.M.B.H.

Effective date: 19991114

CCCH Change of ownership of the supplementary protection certificate

Owner name: SOLVAY PHARMACEUTICALS G.M.B.H.

Spc suppl protection certif: 95C0011

CCCH Change of ownership of the supplementary protection certificate

Owner name: OLVAY PHARMACEUTICALS G.M.B.H.

Spc suppl protection certif: 95C0011

Filing date: 19991114

CCRE Expiry of a supplementary protection certificate

Free format text: PRODUCT NAME: MOCONIDINE-BASE; NAT. REGISTRATION NO/DATE: 410 IS 191 F3 / 19950418; FIRST REGISTRATION: DE 9953.00.00 19910123

Spc suppl protection certif: 95C0011

Filing date: 19951017

Expiry date: 19991114

Extension date: 20041114